These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 11981043

  • 1. A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector.
    Langer I, Vertongen P, Perret J, Waelbroeck M, Robberecht P.
    Mol Endocrinol; 2002 May; 16(5):1089-96. PubMed ID: 11981043
    [Abstract] [Full Text] [Related]

  • 2. A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector.
    Langer I, Vertongen P, Perret J, Waelbroeck M, Robberecht P.
    Biochem Soc Trans; 2002 Aug; 30(4):447-50. PubMed ID: 12196112
    [Abstract] [Full Text] [Related]

  • 3. Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor.
    Langer I, Langlet C, Robberecht P.
    J Mol Endocrinol; 2005 Apr; 34(2):405-14. PubMed ID: 15821106
    [Abstract] [Full Text] [Related]

  • 4. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
    Vertongen P, Langlet C, Langer I, Gaspard N, Robberecht P.
    Peptides; 2004 Nov; 25(11):1943-9. PubMed ID: 15501526
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16.
    Langer I, Perret J, Vertongen P, Waelbroeck M, Robberecht P.
    Cell Calcium; 2001 Oct; 30(4):229-34. PubMed ID: 11587546
    [Abstract] [Full Text] [Related]

  • 6. Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.
    Vertongen P, Solano RM, Perret J, Langer I, Robberecht P, Waelbroeck M.
    Br J Pharmacol; 2001 Aug; 133(8):1249-54. PubMed ID: 11498510
    [Abstract] [Full Text] [Related]

  • 7. Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.
    Perret J, Vertongen P, Solano RM, Langer I, Cnudde J, Robberecht P, Waelbroeck M.
    Br J Pharmacol; 2002 Aug; 136(7):1042-8. PubMed ID: 12145104
    [Abstract] [Full Text] [Related]

  • 8. Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation.
    Langer I, Robberecht P.
    Cell Signal; 2005 Jan; 17(1):17-24. PubMed ID: 15451021
    [Abstract] [Full Text] [Related]

  • 9. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I, Gaspard N, Langlet C, Robberecht P, Langer I.
    Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
    [Abstract] [Full Text] [Related]

  • 10. Identification of a VIP-specific receptor in guinea pig tenia coli.
    Teng BQ, Grider JR, Murthy KS.
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684
    [Abstract] [Full Text] [Related]

  • 11. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
    Igarashi H, Ito T, Pradhan TK, Mantey SA, Hou W, Coy DH, Jensen RT.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
    Van Rampelbergh J, Juarranz MG, Perret J, Bondue A, Solano RM, Delporte C, De Neef P, Robberecht P, Waelbroeck M.
    Br J Pharmacol; 2000 Jun; 130(4):819-26. PubMed ID: 10864888
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.
    Nachtergael I, Vertongen P, Langer I, Perret J, Robberecht P, Waelbroeck M.
    Biochem J; 2003 Mar 15; 370(Pt 3):1003-9. PubMed ID: 12475394
    [Abstract] [Full Text] [Related]

  • 14. Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.
    Juarranz MG, Van Rampelbergh J, Gourlet P, De Neef P, Cnudde J, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1999 Dec 15; 56(6):1280-7. PubMed ID: 10570056
    [Abstract] [Full Text] [Related]

  • 15. Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding.
    Nicole P, Maoret JJ, Couvineau A, Momany FA, Laburthe M.
    Biochem Biophys Res Commun; 2000 Sep 24; 276(2):654-9. PubMed ID: 11027527
    [Abstract] [Full Text] [Related]

  • 16. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
    Park CG, Ganguli SC, Pinon DI, Hadac EM, Miller LJ.
    J Pharmacol Exp Ther; 2000 Nov 24; 295(2):682-8. PubMed ID: 11046106
    [Abstract] [Full Text] [Related]

  • 17. VIP activates G(s) and G(i3) in rat alveolar macrophages and G(s) in HEK293 cells transfected with the human VPAC(1) receptor.
    Shreeve SM, Sreedharan SP, Hacker MP, Gannon DE, Morgan MJ.
    Biochem Biophys Res Commun; 2000 Jun 16; 272(3):922-8. PubMed ID: 10860852
    [Abstract] [Full Text] [Related]

  • 18. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1996 Dec 16; 50(6):1596-604. PubMed ID: 8967982
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
    Juarranz MG, De Neef P, Robberecht P.
    Prostate; 1999 Sep 15; 41(1):1-6. PubMed ID: 10440869
    [Abstract] [Full Text] [Related]

  • 20. A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology.
    Dickson L, Aramori I, McCulloch J, Sharkey J, Finlayson K.
    Neuropharmacology; 2006 Nov 15; 51(6):1086-98. PubMed ID: 16930633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.